Stephen B Keysar Selected Research

Stephen B Keysar Research Topics

Disease

17	Neoplasms (Cancer) 11/2023 - 09/2010
13	Squamous Cell Carcinoma of Head and Neck 11/2023 - 06/2013
5	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2013
2	Neoplasm Metastasis (Metastasis) 10/2013 - 09/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Bites and Stings (Sting) 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Residual Neoplasm 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 08/2013
1	Hypoxia (Hypoxemia) 01/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2018
5	Cetuximab (Erbitux)FDA Link 10/2021 - 06/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2013
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2014
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 10/2013
3	Messenger RNA (mRNA)IBA 10/2021 - 01/2015
2	LigandsIBA 11/2023 - 01/2019
2	Aldehyde DehydrogenaseIBA 01/2017 - 09/2010
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2015
2	IPI-926IBA 02/2016 - 06/2013
2	Monoclonal AntibodiesIBA 01/2015 - 06/2013
2	ON 01910IBA 03/2014 - 10/2013
2	CateninsIBA 03/2014 - 10/2013
2	Polo-Like Kinase 1IBA 03/2014 - 10/2013
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	B7-H1 AntigenIBA 11/2023
1	Conditioned Culture MediaIBA 01/2022
1	Fibronectins (Fibronectin)IBA 10/2021
1	Caveolin 1IBA 10/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	HomoharringtonineIBA 01/2020
1	CytokinesIBA 11/2019
1	MAP-kinase-activated kinase 2IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 11/2019
1	OMP-54F28IBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2015
1	cyclopamineIBA 12/2014
1	Cadherins (E-Cadherin)IBA 10/2013
1	Antineoplastic Agents (Antineoplastics)IBA 08/2013
1	PX-866IBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 06/2013
1	Coloring Agents (Dyes)IBA 09/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2010
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2010

Therapy/Procedure

11	Therapeutics 10/2021 - 09/2010
2	Radiotherapy 11/2019 - 12/2014
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 02/2016